Hepatobiliary Surgery and Liver Transplantation Unit, Cruces University Hospital, Bilbao, Spain; BioCruces Bizkaia Research Health Institute, Barakaldo, Bizkaia, Spain.
Hepatobiliary Surgery and Liver Transplantation Unit, Cruces University Hospital, Bilbao, Spain; BioCruces Bizkaia Research Health Institute, Barakaldo, Bizkaia, Spain.
Transplant Proc. 2022 Nov;54(9):2552-2555. doi: 10.1016/j.transproceed.2022.10.010. Epub 2022 Oct 31.
Renoportal anastomosis (RPA) is an effective technique in cases of complex portal vein thrombosis with the presence of a splenorenal shunt. The objective of this report is to describe the possible complications related to RPA.
A 50-year-old man with alcohol-related and hepatitis C-related cirrhosis and 2 hepatocellular carcinomas underwent liver transplant. He presented a portal vein thrombosis Yerdel IV, a splenorenal shunt, and another shunt between the inferior mesenteric vein (IMV) and the perirectal plexus. During surgery, the flow of the left renal vein was 891 mL/min, and this rose to 1050 mL/min after IMV clamping. RPA was made through iliac vein graft interposition, and the IMV was ligated. Portal flow was 832 mL/min but drastically decreased because of mesenteric root compression. After finishing the liver transplant, a renoiliac graft percutaneous transhepatic stent was put in place. The patient presented graft dysfunction and acute kidney injury. On postoperative day +18, a second stent was put in place because of a thrombosis in the splenomesenteric confluence. The patient subsequently presented partial distal rethrombosis and a pancreaticoduodenal arteriovenous fistula, which required several embolizations. The patient developed ascites, recurrent gastrointestinal bleeding, and persistent bacterial peritonitis. Finally, a modified Sugiura procedure (without splenectomy) was performed, achieving a portal flow of 1800 mL/min. However, the patient developed sepsis and multiorgan failure, and died on postoperative day +70.
Despite long-term patient and graft survival within accepted limits after LT, RPA is a challenging technique not exempt from complications.
肾门静脉吻合术(RPA)是治疗伴有脾肾分流的复杂门静脉血栓形成的有效技术。本报告的目的是描述与 RPA 相关的可能并发症。
一名 50 岁男性,因酒精和丙型肝炎相关的肝硬化和 2 个肝细胞癌接受了肝移植。他患有门静脉血栓形成 Yerdel IV 型、脾肾分流和肠系膜下静脉(IMV)与直肠周围丛之间的另一个分流。手术中,左肾静脉的流量为 891ml/min,IMV 夹闭后增加到 1050ml/min。通过髂静脉移植桥接进行 RPA,结扎 IMV。门静脉流量为 832ml/min,但由于肠系膜根部受压而急剧下降。完成肝移植后,经皮经肝穿刺放置了肾髂吻合支架。患者出现移植物功能障碍和急性肾损伤。术后第 18 天,由于脾肠系膜汇合处血栓形成,再次放置支架。随后患者出现部分远端再血栓形成和胰十二指肠动静脉瘘,需要多次栓塞。患者出现腹水、复发性胃肠道出血和持续性细菌性腹膜炎。最终,进行了改良 Sugiura 手术(无脾切除术),门静脉流量达到 1800ml/min。然而,患者发生脓毒症和多器官衰竭,术后第 70 天死亡。
尽管 LT 后患者和移植物的长期存活率在可接受的范围内,但 RPA 是一项具有挑战性的技术,并非没有并发症。